Middle-aged and older adults
Conditions
Interventions
Placebo (casein) ingestion, 2 months
Lactotripeptides ingestion, 2 months
Placebo (casein) ingestion, 2 months Aerobic exercise (moderate intensity, 30-50 min, 3-6 d/w), 2 months
Lactotripeptides ing
Sponsors
Factory of Health and Sports Science, University of Tsukuba
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Not restricted by a doctor from exercising 2. Not doing moderate- to vigorous-intensity aerobic training 3. Not participate in another clinical trial in one year 4. Not have lactose intolerance 5. Can agree with contents of study 6. Not take angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker
Exclusion criteria
Exclusion criteria: 1. Care-dependent or support-dependent on a Japanese long-term care insurance system 2. Have severe heart disease, cerebrovascular disease, and renal dysfunction 3. Medical doctors can not agree with participation in the study 4. Limited mobility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue (2 months after intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| Vascular function (2 months after intervention) Aerobic capacity (2 months after intervention) Physical performance (2 months after intervention) Biochemical blood test (2 months after intervention) | — |
Countries
Japan
Contacts
Public ContactMasaki Yoshioka
University of Tsukuba Factory of Health and Sports Science
Outcome results
None listed